Clinical, etiological and therapeutic aspects of cerebral folate deficiency. (July 2015)

• Record Type: Journal Article
• Authors: Molero-Luis, Marta; Serrano, Mercedes; O'Callaghan, Maria M; Sierra, Cristina; Pérez-Dueñas, Belén; García-Cazorla, Angels; Artuch, Rafael
• Is Part Of: Expert review of neurotherapeutics. Volume 15:Number 7(2015)
• Page Start: 793
• Page End: 802
• Publication Date: 2015-07
• Subjects: Neuropharmacology -- Periodicals; 615.7805
• DOI: 10.1586/14737175.2015.1055322
• Languages: English
• ISSNs: 1473-7175

Abstract

<abstract> <title> <x xml:space="preserve">Abstract</x> </title> <p>Cerebral folate deficiency is defined as any neurological condition associated with low cerebrospinal fluid folate concentrations. It is becoming increasingly associated with several neurological diseases, either genetic or environmental. Treatment of cerebral folate deficiency by folate supplementation is generally effective, improving the neurological outcome of some patients. However, to treat cerebral folate deficiency, the proper choice of one of the available folate forms is essential. The distinct brain folate metabolism features compared with peripheral folate metabolic pathways strongly suggest the investigation of different folate forms, such as the biologically active folinic acid and 5-methyltetrahydrofolate, since they are efficiently transported to the brain. Regarding the oral doses of the different folate forms, despite the fact that there are some recommendations, there is no general consensus. Further investigation and designing clinical trials are advisable to elucidate these aspects.</p> </abstract>